Figure 1

Patient flowchart.

AEs: adverse events.

C.E.R.A.: Continuous Erythropoietin Receptor Activator.

ITT: intent to treat.

QW: once weekly.

Q3W: once ever 3 weeks.

*One patient in the C.E.R.A. 2.1 μg/kg QW group, three patients in the 2.1 μg/kg Q3W group and one patient in the 6.3 μg/kg Q3W group were excluded from the ITT and safety analyses because they did not receive any study drug.